e-learning
resources
London 2016
Sunday, 04.09.2016
Infections, sepsis, and pulmonary embolism
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary originated sepsis: Can N/L ratio be used as follow-up marker?
Rabia Sari (istanbul, Turkey), Rabia Sari, Mustafa Ay, Emin Çelik, Ülgen Yalaz Tekan, Fulya Çiyiltepe, Feyza Kargin, Cuneyt Salturk, Özlem Mocin, Gokay Gungor, Nalan Adiguzel, Zuhal Karakurt
Source:
International Congress 2016 – Infections, sepsis, and pulmonary embolism
Session:
Infections, sepsis, and pulmonary embolism
Session type:
Poster Discussion
Number:
355
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Rabia Sari (istanbul, Turkey), Rabia Sari, Mustafa Ay, Emin Çelik, Ülgen Yalaz Tekan, Fulya Çiyiltepe, Feyza Kargin, Cuneyt Salturk, Özlem Mocin, Gokay Gungor, Nalan Adiguzel, Zuhal Karakurt. Pulmonary originated sepsis: Can N/L ratio be used as follow-up marker?. Eur Respir J 2016; 48: Suppl. 60, 355
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Related content which might interest you:
Endothelial dysfunction in pulmonary embolism: Neutrophil-lymphocyte and platelet-lymphocyte ratio
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
C-reactive protein and pulmonary tuberculosis: What correlation with disease severity
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015
Endothelial dysfunction and prognostic significance of endothelin-1 in patients with severe pneumonia and pulmonary sepsis
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
Is serum cystatin C a predictor of acute pulmonary thromboembolism in patients with normal renal function?
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Conduct of a biomarker study in bronchiectasis patients: Correlation of neutrophil elastase activity and inflammatory load in induced sputum
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Usefulness of procalcitonin as a predictor for bacteremia and prognosis in severe sepsis
Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Year: 2016
The role of procalcitonin (PCT) in differential diagnosis of pneumonia and pulmonary congestion associated with end-stage renal failure (ESRF)
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Assessment of inflammatory biomarkers and oxidative stress in pulmonary thromboembolism
Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism
Year: 2013
Electrocardiographic abnormalities in patients with low or moderate risk pulmonary embolism: Prevalence and association with PO
2
/FiO
2
ratio
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Asthma and the risk of pulmonary embolism
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016
Sputum YKL-40 is a potential biomarker of COPD-asthma overlap
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Biomarkers of systemic inflammatory response in patients with tuberculosis, combined with HIV infection
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016
Lung functional decline in patients with Interstitial Pneumonia with Autoimmune Features (IPAF)
Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Year: 2021
Inflammatory markers and community acquired pneumonia (CAP): Prognosis analisis and predictive capacity in the short term
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Pulmonary hypertension and COPD: Clinical assessment and biomarkers
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013
The role of procalcitonin in predicting severity and clinical course of aspiration pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Accuracy of inflammatory markers to distinguish between pneumonia and pulmonary embolism in acute settings
Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots
Year: 2015
The prognostic value of consecutive C-reactive protein measurements in community acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Could uric acid be a marker of poor prognosis for pulmonary embolism?
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept